Patents by Inventor Virginia D. SCHMITH

Virginia D. SCHMITH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ADMINISTERING DEFLAZACORT THERAPY
    Publication number: 20210361676
    Abstract: The disclosure provides a deflazacort therapy comprising, administering to a subject suffering from Duchenne muscular dystrophy (DMD) a fixed dose of deflazacort. Also provided is a deflazacort therapy comprising, increasing the deflazacort dosage when the subject loses ambulation; or, increasing the dosage of deflazacort administered during concomitant administration of a CYP3A4 inducer; or, decreasing the dosage of deflazacort administered during concomitant administration of a CYP3A inhibitor.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Inventors: Stephen P. Wanaski, Virginia D. Schmith, Linda L. Grasfeder, Scott Joseph Brantley
  • Methods of administering deflazacort therapy
    Patent number: 11083737
    Abstract: The disclosure provides a deflazacort therapy comprising, administering to a subject suffering from Duchenne muscular dystrophy (DMD) a fixed dose of deflazacort. Also provided is a deflazacort therapy comprising, increasing the deflazacort dosage when the subject loses ambulation; or, increasing the dosage of deflazacort administered during concomitant administration of a CYP3A4 inducer; or, decreasing the dosage of deflazacort administered during concomitant administration of a CYP3A inhibitor.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: August 10, 2021
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Stephen P. Wanaski, Virginia D. Schmith, Linda L. Grasfeder, Scott Joseph Brantley
  • TOPICAL COMPOSITIONS FOR TREATMENT OF EXCESSIVE SWEATING AND METHODS OF USE THEREOF
    Publication number: 20160166487
    Abstract: The present invention provides for 4-[hydroxy(diphenyl)methyl]-1-{2-[(phenylmethyl)oxy]ethyl}-1-azoniabicyclo[2.2.2]octane and a pharmaceutically acceptable anion thereof for use in the topical treatment or prophylaxis of excessive sweating, and compositions containing these ingredients.
    Type: Application
    Filed: July 30, 2014
    Publication date: June 16, 2016
    Inventors: Teodora PENE DUMITRESCU, Elizabeth K. HUSSEY, Maria Graziella LARM, Jon D. LENN, Leon LOUPENOK, Michael R. LUKE, Leandro L. SANTOS, Virginia D. SCHMITH
  • TOPICAL COMPOSITIONS FOR TREATMENT OF EXCESSIVE SWEATING AND METHODS OF USE THEREOF
    Publication number: 20150037269
    Abstract: The present invention provides for 4-[hydroxy(diphenyl)methyl]-1-{2-[(phenylmethyl)oxy]ethyl}-1-azoniabicyclo[2.2.2]octane and a pharmaceutically acceptable anion thereof for use in the topical treatment or prophylaxis of excessive sweating, and compositions containing these ingredients.
    Type: Application
    Filed: July 30, 2014
    Publication date: February 5, 2015
    Inventors: Teodora Pene DUMITRESCU, Elizabeth K. HUSSEY, Maria Graziella LARM, Jon LENN, Leon LOUPENOK, Michael R. LUKE, Leandro L. SANTOS, Virginia D. SCHMITH